Boston Scientific Medical Device Malaysia Sdn. Bhd. Sustainability Profile
Boston Scientific Medical Device Malaysia Sdn. Bhd., a subsidiary of the renowned Boston Scientific Corporation, is headquartered in Malaysia and operates extensively across the Asia-Pacific region. Established in 1994, the company has made significant strides in the medical device industry, focusing on innovative solutions in areas such as cardiovascular, rhythm management, and urology. With a commitment to advancing healthcare, Boston Scientific Malaysia offers a diverse range of products, including cutting-edge stents, catheters, and surgical instruments. Their unique approach combines advanced technology with a patient-centric philosophy, ensuring high-quality outcomes. Recognised for its contributions to medical advancements, the company holds a strong market position, continually striving to enhance the lives of patients through its pioneering medical devices.
DitchCarbon Score
How does Boston Scientific Medical Device Malaysia Sdn. Bhd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boston Scientific Medical Device Malaysia Sdn. Bhd.'s score of 89 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boston Scientific Medical Device Malaysia Sdn. Bhd. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family, with emissions data and climate commitments cascaded from its parent organisation, Boston Scientific Corporation. Boston Scientific Corporation has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to enhance sustainability and reduce carbon footprints across their operations. While specific reduction targets for Boston Scientific Medical Device Malaysia Sdn. Bhd. are not detailed, the overarching commitments from the parent company reflect a strong dedication to addressing climate change. As a current subsidiary, Boston Scientific Medical Device Malaysia Sdn. Bhd. aligns with the climate strategies and performance metrics of Boston Scientific Corporation, which are designed to drive significant reductions in greenhouse gas emissions across all scopes. The company is committed to contributing to these efforts, although specific local targets and achievements have not been disclosed. In summary, while direct emissions data for Boston Scientific Medical Device Malaysia Sdn. Bhd. is not available, the organisation is integrated into a robust framework of climate commitments and initiatives led by Boston Scientific Corporation, focusing on sustainability and emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Boston Scientific Medical Device Malaysia Sdn. Bhd.'s Industry?
How Carbon Intensive is Boston Scientific Medical Device Malaysia Sdn. Bhd.'s Location?
Boston Scientific Medical Device Malaysia Sdn. Bhd.'s Scope 3 Categories Breakdown
Boston Scientific Medical Device Malaysia Sdn. Bhd.'s Scope 3 emissions, which increased by 28% last year and decreased by approximately 7% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 57% of Scope 3 emissions.
Top Scope 3 Categories
Boston Scientific Medical Device Malaysia Sdn. Bhd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Boston Scientific Medical Device Malaysia Sdn. Bhd. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.